Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6702 EUR | -1.74% | -8.19% | -67.15% |
May. 14 | Biophytis unveils design for obesity study | CF |
May. 14 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
Sales 2024 * | - | Sales 2025 * | 4.8M 5.22M | Capitalization | 1.92M 2.09M |
---|---|---|---|---|---|
Net income 2024 * | -19M -20.68M | Net income 2025 * | -16M -17.42M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.4 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
1 day | -1.74% | ||
1 week | -8.19% | ||
Current month | -2.87% | ||
1 month | -15.16% | ||
3 months | -60.11% | ||
6 months | -70.08% | ||
Current year | -67.15% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 0.6702 | -1.74% | 27,178 |
24-06-03 | 0.6821 | -1.14% | 12,524 |
24-05-31 | 0.69 | -1.41% | 18,656 |
24-05-30 | 0.6999 | -4.12% | 43,018 |
24-05-29 | 0.73 | 0.00% | 10,235 |
Real-time Euronext Paris, June 04, 2024 at 11:11 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-67.15% | 2.12M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- ALBPS Stock